Evidence map›Paper›PMID 30972047›Full record

ArticleFrontiers in microbiology2019

Effect of Nicotinamide Against

XinRui Xing, ZeBin Liao, Fei Tan, ZhenYu Zhu, Yuanying Jiang, YingYing Cao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Microorganisms · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. [Research Progress in Niacinamide in the Prevention and Treatment of Mouth and Systemic Diseases].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2023
    Review
  17. Article
  18. Article
  19. Antibiotics (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

XinRui XingShanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
ZeBin LiaoSchool of Pharmacy, Second Military Medical University, Shanghai, China.
Fei TanShanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
ZhenYu ZhuSchool of Pharmacy, Second Military Medical University, Shanghai, China.
Yuanying JiangDepartment of Pharmacology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
YingYing CaoShanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Second Military Medical University · CNTongji University · CNShanghai Skin Disease Hospital · CNShanghai Tenth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotinamide (NAM) has a long history in clinical applications and can be safely used for treating various diseases. In recent years, NAM was found to exhibit antimicrobial activities, inhibiting the growth of

Indexed as

Candida albicansdrug resistancefluconazoleGIN4nicotinamide

Identifiers

PMID30972047
PMCPMC6443637
OpenAlexW2922673069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.